Therapeutic mesenchymal stem cells in rheumatic diseases: rationale, clinical data and perspectives

David Guérit 1 Marie Maumus 2 Florence Apparailly 2 Christian Jorgensen 2, 3 Danièle Noël 2, *
* Auteur correspondant
1 U844
Cellules souches mésenchymateuses, environnement articulaire et immunothérapies de la polyarthrite rhumatoide
Abstract : Mesenchymal stem or stromal cells (MSCs) are easily isolated from bone marrow or fat tissue and their potential of multilineage differentiation has initially led to the development of strategies for tissue engineering applications. More recently, they have gained much interest based on their trophic and immunomodulatory properties that have stimulated their evaluation in various clinical trials aiming at modulating the host immune response in graft-versus-host disease or autoimmune diseases. The clinical applications of MSCs for rheumatic diseases are limited and address primarily their potential to help tissue repair/regeneration. The aim of the present review is to focus on the mechanisms by which MSCs might exhibit a therapeutic potential in rheumatology and present the current data on the undergoing clinical trials. Special attention is given to miRNA expression in rheumatic pathologies and their possible modulation for future innovative strategies as biomarkers or therapeutic targets.
Type de document :
Article dans une revue
Clinical Investigation, 2011, 1 (9), pp.1269-1277
Liste complète des métadonnées

Littérature citée [63 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00644029
Contributeur : Danièle Noël <>
Soumis le : lundi 1 octobre 2012 - 07:00:38
Dernière modification le : mardi 31 octobre 2017 - 10:20:04
Document(s) archivé(s) le : mercredi 2 janvier 2013 - 02:35:15

Fichiers

1103-ClinInvest-revised.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-00644029, version 1

Collections

Citation

David Guérit, Marie Maumus, Florence Apparailly, Christian Jorgensen, Danièle Noël. Therapeutic mesenchymal stem cells in rheumatic diseases: rationale, clinical data and perspectives. Clinical Investigation, 2011, 1 (9), pp.1269-1277. 〈inserm-00644029〉

Partager

Métriques

Consultations de la notice

172

Téléchargements de fichiers

494